Our previous papers introduced a practical approach to measuring medical impact, learnings around operational effectiveness, and best practices for assessing and measuring valuable relationships — one of the three enablers in the medical impact model.

This paper will focus on the enabler, actionable insights. Insights, derived from interactions with HCPs, KOLs, and patients, are crucial for making informed decisions about product development, launch strategies, operational tactics,  and ongoing product lifecycle management. Most organizations have insights processes and some metrics in place, but as technology progresses, the possibilities for capturing and analyzing insights are rapidly evolving.

Disseminating information more efficiently allows all functions to act quickly with the ultimate goal being to positively impact patients. Now is an opportune time to review your own processes and explore new approaches and updates. To bring this topic to life and provide examples of how biopharmas are advancing this area, we’ve gathered learnings and best practices from industry leaders.

Christoph Bug, MD, PhD, MBA

Vice President, Global Medical

Veeva